Fear of Disease Progression in Patients with Multiple Sclerosis: Associations of Anxiety, Depression, Quality of Life, Social Support and Knowledge

  • Morteza Ghojazadeh
  • Mahnaz Taghizadeh
  • Salman Abdi
  • Saber Azami-Aghdash
  • Sasan Andalib Neurosciences Research Center (NSRC), Imam Reza Medical Center, Tabriz University of Medical Sciences,Tabriz, Iran
  • Mehdi Farhoudi


Purpose: Fear of progression of multiple sclerosis (MS) can exert deleterious effects upon MS patients. A host of causes may give rise to fear of progression of multiple sclerosis. Hence, the present study set out to assess the role of psychological aspects of family support, quality of life, and multiple sclerosis knowledge in fear of progression of MS.

Methods: Sixty five MS patients were recruited for this study. Data were obtained by using multiple questionnaires including Multiple Sclerosis Knowledge Questionnaire (MSKQ), Fear of progression questionnaire - Short form (FoPQ-SF), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), World health organization’s quality of life- brief (WHQOL-BRIEF).

Results: age and level of education were not associated with the score of other questionnaires. Depression, anxiety, MS knowledge and three subcategories of WHOQOL-BREF (Environment, Social relationship and Psychological health) were correlated to fear of progression of MS (P<0.001). Anxiety was positively predictive of fear of progression of MS; nonetheless, MS knowledge and QOL-Psychological health were inversely associated with fear of progression of MS (P<0.05).

Conclusion: The present study suggests that anxiety, MS knowledge and QOL-Psychological health are associated with fear of progression of MS. Thus, these parameters can be utilizedfor management and health-care policies of MS.

Author Biography

Sasan Andalib, Neurosciences Research Center (NSRC), Imam Reza Medical Center, Tabriz University of Medical Sciences,Tabriz, Iran


Baghaei P, Zandi M, Vares Z, Masoodialavi N, Adidhajbagheri M: Self-care behaviour of patients with diabetes in kashan centers of diabetes. Quarterly Journal of feiz 2008,12:88-93.

Werring D, Thompson A: Improving the quality of life of patients with multiple sclerosis. DrugsToday 1998,34:145-56.

Murray TJ: Multiple sclerosis: the history of a disease. New York: Demos medical publishing; 2005.

Andreoli A, Thomas E, Russell L: Inflammatory and demyelinative disease. Andreoli A, Thomas E, Russell L: Cecil essentials of medicine. 5th ed. England: MacGraw Hill; 2001:1179-86.

Stuifbergen AK, Blozis SA, Harrison TC, Becker HA: Exercise, functional limitations, and quality of life: A longitudinal study of persons with multiple sclerosis. Archives of physical medicine and rehabilitation 2006,87:935-43. doi: 10.1016/j.apmr.2006.04.003.

Mandysova P: Knowing the course of multiple sclerosis. Journal of Neuroscience Nursing 1998,28:12-6.

Andalib S, Talebi M, Sakhinia E, Farhoudi M, Sadeghi-Bazargani H, Motavallian A, et al: Multiple sclerosis and mitochondrial gene variations: A review 2013, 330(1-2): 10-15. doi: 10.1016/j.jns.2013.04.018.

Talebi M, Nikanfar M, Sorkhabi R, Sharifipour E, Barebar M, Kiavar A, et al: Optic coherence tomography findings in relapsing-remitting multiple sclerosis of the northwest of Iran. Iran J Neurol 2013,12(3): 81-86.

Strober LB, Christodoulou C, Benedict RH, Westervelt HJ, Melville P, Scherl WF, et al: Unemployment in multiple sclerosis: the contribution of personality and disease. Multiple Sclerosis Journal 2012,18:647-53. doi: 10.1177/1352458511426735.

Hadjimichael O, Vollmer T, Oleen-Burkey M: Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 2008,6:100. doi: 10.1186/1477-7525-6-100.

Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT: Relationships between multiple sclerosis and depression. The Journal of neuropsychiatry and clinical neurosciences 2011,23:198-200.

Compston A, Coles A: Multiple sclerosis. Lancet 2008,372:1502-17. doi: 10.1016/S0140-6736(08)61620-7.

Rudick RA, Miller D, Hass S, Hutchinson M, Calabresi PA, Confavreux C, et al: Health-related quality of life in multiple sclerosis: effects of natalizumab. Annals of neurology 2007,62:335-46. doi: 10.1002/ana.21163.

Krupp L, Christodoulou C, Melville P, Scherl W, Pai L-Y, Muenz L, et al: Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis. Neurology 2011,76:1500-7. doi: 10.1212/WNL.0b013e318218107a.

Yu HJ, Christodoulou C, Bhise V, Greenblatt D, Patel Y, Serafin D, et al: Multiple white matter tract abnormalities underlie cognitive impairment in RRMS. Neuroimage 2012,59:3713-22. doi: 10.1016/j.neuroimage.2011.10.053.

Kwakkenbos L, van den Hoogen FH, Custers J, Prins J, Vonk MC, van Lankveld WG, et al: Validity of the Fear of Progression Questionnaire, Short Form in patients with systemic sclerosis. Arthritis Care & Research 2012,64:930-4. doi: 10.1002/acr.21618.

Siegert R, Abernethy D: Depression in multiple sclerosis: a review. Journal of Neurology, Neurosurgery & Psychiatry 2005,76:469-75. doi:10.1136/jnnp.2004.054635.

Korostil M, Feinstein A: Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis 2007,13:67-72. doi: 10.1177/1352458506071161.

Wood B, van der Mei I, Ponsonby A, Pittas F, Quinn S, Dwyer T, et al: Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Multiple Sclerosis Journal 2013,19:217-24. doi: 10.1177/1352458512450351.

Stafford L, Judd F: What do women with gestational trophoblastic disease understand about the condition? International Journal of Gynecological Cancer 2011,21:161-6. doi: 10.1097/IGC.0b013e31820156d8.

Wandwalo E, Morkve O: Knowledge of disease and treatment among tuberculosis patients in Mwanza, Tanzania. The International Journal of Tuberculosis and Lung Disease 2000,4:1041-6.

Chen S-Y, Wang H-H: The relationship between physical function, knowledge of disease, social support and self-care behavior in patients with rheumatoid arthritis. Journal of Nursing Research 2007,15:183-92.

Russell CS, White MB, White CP: Why me? Why now? Why multiple sclerosis?: Making meaning and perceived quality of life in a Midwestern sample of patients with multiple sclerosis. Families, Systems, & Health 2006,24:65.

Hemmett L, Holmes J, Barnes M, Russell N: What drives quality of life in multiple sclerosis? QJM 2004,97:671-6. doi: 10.1093/qjmed/hch105.

Foley JF, Brandes DW: Redefining functionality and treatment efficacy in multiple sclerosis. Neurology 2009,72:S1-S11. doi: 10.1212/WNL.0b013e3181a99bc2.

Haussleiter IS, Brüne M, Juckel G: Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Therapeutic advances in neurological disorders 2009,2:13-29. doi: 10.1177/1756285608100325.

Kwakkenbos L, van Lankveld WG, Vonk MC, Becker ES, van den Hoogen FH, van den Ende CH: Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. Journal of psychosomatic research 2012,72:199-204. doi:10.1016/j.jpsychores.2011.12.005.

Wang Q, Hay M, Clarke D, Menahem S: Associations between knowledge of disease, depression and anxiety, social support, sense of coherence and optimism with health-related quality of life in an ambulatory sample of adolescents with heart disease. Cardiology in the Young 2014,24:126-133. doi: 10.1017/S1047951113000012.

Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: psychometric properties. Journal of consulting and clinical psychology 1988,56:893. doi:10.1037/0022-006X.56.6.893.

Beck AT, Ward C, Mendelson M: Beck depression inventory (BDI). Arch Gen Psychiatry 1961,4:561-71.

Basker M, Moses PD, Russell S, Russell PS: The psychometric properties of Beck Depression Inventory for adolescent depression in a primary-care paediatric setting in India. Child Adolesc Psychiatry Ment Health 2007,1:8. doi: 10.1186/1753-2000-1-8.

Skevington SM, Lotfy M, O'Connell KA: The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of life Research 2004,13:299-310.

Nedjat S, Montazeri A, Holakouie K, Mohammad K, Majdzadeh R: Psychometric properties of the Iranian interview-administered version of the World Health Organization's Quality of Life Questionnaire (WHOQOL-BREF): a population-based study. BMC Health Services Research 2008,8:61. doi:10.1186/1472-6963-8-61.

Giordano A, Uccelli MM, Pucci E, Martinelli V, Borreani C, Lugaresi A, et al: The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients. Multiple Sclerosis 2010,16:100-11. doi: 10.1177/1352458509352865.

Norbeck JS, Lindsey AM, Carrieri VL: Further development of the Norbeck Social Support Questionnaire: Normative data and validity testing. Nursing research 1983,32:4-9.

Gigliotti E: A confirmatory factor analysis of situation-specific Norbeck social support questionnaire items. Nursing research 2006,55:217-22.

Amiri S, Khousheh M, Ranjbar F, Fakhari A, Mohagheghi A, Farnam A, et al: Factors Related to Marital Satisfaction in Women with Major Depressive Disorder. Iranian journal of psychiatry 2012,7:164.

Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, et al: Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. Journal of psychosomatic research 2005,58:505-11.

Laforce JR R, McLean S: Knowledge and fear of developing alzheimer's disease in a sample of healthy adults. Psychological reports 2005,96:204-6. doi: 10.2466/pr0.96.1.204-206.

Herschbach P, Book K, Dinkel A, Berg P, Waadt S, Duran G, et al: Evaluation of two group therapies to reduce fear of progression in cancer patients. Supportive care in cancer 2010,18:471-9. doi: 10.1007/s00520-009-0696-1.

Koch L, Jansen L, Brenner H, Arndt V: Fear of recurrence and disease progression in long‐term (≥ 5 years) cancer survivors—a systematic review of quantitative studies. Psycho‐Oncology 2013,22:1-11. doi: 10.1002/pon.3022.

Zimmermann T, Herschbach P, Wessarges M, Heinrichs N: Fear of progression in partners of chronically ill patients. Behavioral Medicine 2011,37:95-104. doi:10.1080/08964289.2011.605399.

Tanrverdi D, Okanl A, Sezgin S, Ekinci M: Quality of life in patients with multiple sclerosis in Turkey: relationship to depression and fatigue. Journal of Neuroscience Nursing 2010,42:267-73.

Wu N, Minden SL, Hoaglin DC, Hadden L, Frankel D: Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. Journal of health and human services administration 2007:233-67.

How to Cite
Ghojazadeh, M., Taghizadeh, M., Abdi, S., Azami-Aghdash, S., Andalib, S., & Farhoudi, M. (2014). Fear of Disease Progression in Patients with Multiple Sclerosis: Associations of Anxiety, Depression, Quality of Life, Social Support and Knowledge. Journal of Clinical Research & Governance, 3(2), 141-146. https://doi.org/10.13183/jcrg.v3i2.105
Research Articles

Most read articles by the same author(s)